Haemodynamic regulation of gene expression in vascular tissue engineering

Current Vascular Pharmacology

Volumn 9, Issue 2, 2011, Pages 167-187

  Vara, Dina S ^a   Punshon, Geoffrey ^a   Sales, Kevin M ^a   Hamilton, George ^b   Seifalian, Alexander M ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Biomaterials; Drug delivery; Endothelial cells; Gene expression; Intimal hyperplasia; Patency; Shear stress

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOPOIETIN RECEPTOR; BASIC FIBROBLAST GROWTH FACTOR; CLOPIDOGREL; COLLAGEN TYPE 7; CYCLOPHOSPHAMIDE; CYTOCHROME P450 2C; DACTINOMYCIN; DOCETAXEL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PACLITAXEL; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNINDEXED DRUG; UROKINASE; VASCULAR CELL ADHESION MOLECULE 1; WARFARIN;

ANGIOGENESIS; ARTERY THROMBOSIS; ATHEROGENESIS; BLOOD VESSEL GRAFT; CELL ADHESION; CELL JUNCTION; CELL PROLIFERATION; CELL SHAPE; COCULTURE; CORONARY ARTERY ATHEROSCLEROSIS; CYTOSKELETON; DACRON IMPLANT; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GRAFT FAILURE; GRAFT OCCLUSION; GRAFT PATENCY; GRAFT SURVIVAL; HEMODYNAMICS; HUMAN; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; MATERIAL COATING; NONHUMAN; POLITEF IMPLANT; REVIEW; SHEAR RATE; SHEAR STRESS; SMOOTH MUSCLE FIBER; TENSILE STRENGTH; THROMBOCYTE AGGREGATION INHIBITION; TISSUE ENGINEERING; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULAR TISSUE;

ANIMALS; BLOOD VESSEL PROSTHESIS; CELL ADHESION; CYTOSKELETON; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; GRAFT SURVIVAL; HEMODYNAMICS; HUMANS; MUSCLE, SMOOTH, VASCULAR; TISSUE ENGINEERING;

EID: 79951686432     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016111794519390     Document Type: Review

References (289)

1. Burkel WE. The challenge of small diameter vascular grafts. Med Prog Technol 1988; 14: 165-75.
2. Cikirikcioglu M, Pektok E, Cikirikcioglu YB, et al. Matching the diameter of ePTFE bypass prosthesis with a native artery improves neoendothelialization. Eur Surg Res 2008; 40: 333-40.
3. Kannan RY, Salacinski HJ, Butler PE, Seifalian AM. Polyhedral oligomeric silsesquioxane nanocomposites: the next generation material for biomedical applications. Acc Chem Res 2005; 38: 879-84.
4. Kannan RY, Salacinski HJ, Ghanavi JE, et al. Silsesquioxane nanocomposites as tissue implants. Plast Reconstr Surg 2007; 119: 1653-62.
5. Raghunath J, Zhang H, Edirisinghe MJ, Darbyshire A, Butler PE, Seifalian AM. A new biodegradable nanocomposite based on polyhedral oligomeric silsesquioxane nanocages: cytocompatibility and investigation into electrohydrodynamic jet fabrication techniques for tissue-engineered scaffolds. Biotechnol Appl Biochem 2009; 52: 1-8.
6. Deutsch M, Meinhart J, Fischlein T, Preiss P, Zilla P. Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience. Surgery 1999; 126: 847-55.
7. Seifalian AM, Tiwari A, Hamilton G, Salacinski HJ. Improving the clinical patency of prosthetic vascular and coronary bypass grafts: the role of seeding and tissue engineering. Artif Organs 2002; 26: 307-20.
8. Dardik A, Liu A, Ballermann BJ. Chronic in vitro shear stress stimulates endothelial cell retention on prosthetic vascular grafts and reduces subsequent in vivo neointimal thickness. J Vasc Surg 1999; 29: 157-67.
9. Tiwari A, Salacinski HJ, Punshon G, Hamilton G, Seifalian AM. Development of a hybrid cardiovascular graft using a tissue engineering approach. FASEB J 2002; 16: 791-6.
10. Matlung HL, Bakker EN, VanBavel E. Shear stress, reactive oxygen species, and arterial structure and function. Antioxid Redox Signal 2009; 11: 1699-709.
11. Hahn C, Schwartz MA. Mechanotransduction in vascular physiology and atherogenesis. Nat Rev Mol Cell Biol 2009; 10: 53-62.
12. Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood 1996; 88: 1525-41.
13. Turitto VT. Blood viscosity, mass transport, and thrombogenesis. Prog Hemost Thromb 1982; 6: 139-77.
14. Vimmr J, Jonasova A. Non-Newtonian effects of blood flow in complete coronary and femoral bypasses. Math Comput Simul 2010; 80: 1324-36.
15. Wootton DM, Ku DN. Fluid mechanics of vascular systems, diseases, and thrombosis. Annu Rev Biomed Eng 1999; 1: 299-329.
16. Gotlieb AI, Langille BL. The role of rheology in atherosclerotic coronary artery disease. In: Fuster V, Ross R, Topol EL, Eds. Atherosclerosis and Coronary Artery Disease. Philadelphia: Lippincott-Raven 1996; vol. 1: pp. 511-8.
17. Zamir M. Shear forces and blood vessel radii in the cardiovascular system. J Gen Physiol 1977; 69: 449-61.
18. Golledge J, Turner RJ, Harley SL, Springall DR, Powell JT. Circumferential deformation and shear stress induce differential responses in saphenous vein endothelium exposed to arterial flow. J Clin Invest 1997; 99: 2719-26.
19. Hahn C, Schwartz MA. The role of cellular adaptation to mechanical forces in atherosclerosis. Arterioscler Thromb Vasc Biol 2008; 28: 2101-7.
20. Fry DL. Acute vascular endothelial changes associated with increased blood velocity gradients. Circ Res 1968; 22: 165-97.
21. Ruggeri ZM. Mechanisms initiating platelet thrombus formation. Thromb Haemost 1997; 78: 611-6.
22. Reneman RS, Arts T, Hoeks AP. Wall shear stress-an important determinant of endothelial cell function and structure--in the arterial system in vivo. Discrepancies with theory. J Vasc Res 2006; 43: 251-69.
23. Chiu JJ, Usami S, Chien S. Vascular endothelial responses to altered shear stress: Pathologic implications for atherosclerosis. Ann Med 2009; 41: 19-28.
24. Gimbrone MA, Jr., Topper JN, Nagel T, Anderson KR, Garcia-Cardena G. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci 2000; 902: 230-9.
25. Cunningham KS, Gotlieb AI. The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest 2005; 85: 9-23.
26. World CJ, Garin G, Berk B. Vascular shear stress and activation of inflammatory genes. Curr Atheroscler Rep 2006; 8: 240-4.
27. Ohashi T, Sato M. Remodeling of vascular endothelial cells exposed to fluid shear stress: experimental and numerical approach. Fluid Dyn Res 2005; 37: 40-59.
28. Helmlinger G, Geiger RV, Schreck S, Nerem RM. Effects of pulsatile flow on cultured vascular endothelial cell morphology. J Biomech Eng 1991; 113: 123-31.
29. Iruela-Arispe ML, Davis GE. Cellular and molecular mechanisms of vascular lumen formation. Dev Cell 2009; 16: 222-31.
30. Liu Y, Lai Y, Nagaraj A, et al. Pulsatile flow simulation in arterial vascular segments with intravascular ultrasound images. Med Eng Phys 2001; 23: 583-95.
31. Bacabac RG, Smit TH, Cowin SC, et al. Dynamic shear stress in parallel-plate flow chambers. J Biomech 2005; 38: 159-67.
32. Buschmann MH, Dieterich P, Adams NA, Schnittler HJ. Analysis of flow in a cone-and-plate apparatus with respect to spatial and temporal effects on endothelial cells. Biotechnol Bioeng 2005; 89: 493-502.
33. Ueda A, Koga M, Ikeda M, Kudo S, Tanishita K. Effect of shear stress on microvessel network formation of endothelial cells with in vitro three-dimensional model. Am J Physiol Heart Circ Physiol 2004; 287: H994-1002.
34. Kataoka N, Ujita S, Sato M. Effect of flow direction on the morphological responses of cultured bovine aortic endothelial cells. Med Biol Eng Comput 1998; 36: 122-8.
35. Nerem RM, Levesque MJ, Cornhill JF. Vascular endothelial morphology as an indicator of the pattern of blood flow. J Biomech Eng 1981; 103: 172-6.
36. del Alamo JC, Norwich GN, Li YS, Lasheras JC, Chien S. Anisotropic rheology and directional mechanotransduction in vascular endothelial cells. Proc Natl Acad Sci USA 2008; 105: 15411-6.
37. Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol 2007; 49: 2379-93.
38. Wang Y, Miao H, Li S, et al. Interplay between integrins and FLK-1 in shear stress-induced signaling. Am J Physiol Cell Physiol 2002; 283: C1540-C1547.
39. Jalali S, del Pozo MA, Chen K, et al. Integrin-mediated mechanotransduction requires its dynamic interaction with specific extracellular matrix (ECM) ligands. Proc Natl Acad Sci USA 2001; 98: 1042-6.
40. Chachisvilis M, Zhang YL, Frangos JA. G protein-coupled receptors sense fluid shear stress in endothelial cells. Proc Natl Acad Sci USA 2006; 103: 15463-8.
41. Yamamoto K, Sokabe T, Matsumoto T, et al. Impaired flowdependent control of vascular tone and remodeling in P2X4- deficient mice. Nat Med 2006; 12: 133-7.
42. Tzima E, Irani-Tehrani M, Kiosses WB, et al. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 2005; 437: 426-31.
43. Haidekker MA, L'Heureux N, Frangos JA. Fluid shear stress increases membrane fluidity in endothelial cells: a study with DCVJ fluorescence. Am J Physiol Heart Circ Physiol 2000; 278: H1401-H1406.
44. Potter DR, Damiano ER. The hydrodynamically relevant endothelial cell glycocalyx observed in vivo is absent in vitro. Circ Res 2008; 102: 770-6.
45. Chien S. Mechanotransduction and endothelial cell homeostasis: the wisdom of the cell. Am J Physiol Heart Circ Physiol 2007; 292: H1209-H1224.
46. Orr AW, Ginsberg MH, Shattil SJ, Deckmyn H, Schwartz MA. Matrix-specific suppression of integrin activation in shear stress signaling. Mol Biol Cell 2006; 17: 4686-97.
47. Tzima E, del Pozo MA, Shattil SJ, Chien S, Schwartz MA. Activation of integrins in endothelial cells by fluid shear stress mediates Rho-dependent cytoskeletal alignment. EMBO J 2001; 20: 4639-47.
48. Katsumi A, Orr AW, Tzima E, Schwartz MA. Integrins in mechanotransduction. J Biol Chem 2004; 279: 12001-4.
49. Michiels C. Endothelial cell functions. J Cell Physiol 2003; 196: 430-43.
50. Osawa M, Masuda M, Kusano K, Fujiwara K. Evidence for a role of platelet endothelial cell adhesion molecule-1 in endothelial cell mechanosignal transduction: is it a mechanoresponsive molecule? J Cell Biol 2002; 158: 773-85.
51. Dejana E, Orsenigo F, Molendini C, Baluk P, McDonald DM. Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees. Cell Tissue Res 2009; 335: 17-25.
52. Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 2004; 84: 869-901.
53. Laughlin MH, Newcomer SC, Bender SB. Importance of hemodynamic forces as signals for exercise-induced changes in endothelial cell phenotype. J Appl Physiol 2008; 104: 588-600.
54. Chen BP, Li YS, Zhao Y, et al. DNA microarray analysis of gene expression in endothelial cells in response to 24-h shear stress. Physiol Genomics 2001; 7: 55-63.
55. Wasserman SM, Mehraban F, Komuves LG, et al. Gene expression profile of human endothelial cells exposed to sustained fluid shear stress. Physiol Genomics 2002; 12: 13-23.
56. Schlunegger MP, Grutter MG. An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-beta 2. Nature 1992; 358: 430-4.
57. Yang S, Toy K, Ingle G, et al. Vascular endothelial growth factorinduced genes in human umbilical vein endothelial cells: relative roles of KDR and Flt-1 receptors. Arterioscler Thromb Vasc Biol 2002; 22: 1797-803.
58. McCormick SM, Eskin SG, McIntire LV, et al. DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells. Proc Natl Acad Sci USA 2001; 98: 8955-60.
59. Conway DE, Sakurai Y, Weiss D, et al. Expression of CYP1A1 and CYP1B1 in human endothelial cells: regulation by fluid shear stress. Cardiovasc Res 2009; 81: 669-77.
60. Dekker RJ, van SS, Fontijn RD, et al. Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Kruppel-like factor (KLF2). Blood 2002; 100: 1689-98.
61. McCormick SM, Frye SR, Eskin SG, et al. Microarray analysis of shear stressed endothelial cells. Biorheology 2003; 40: 5-11.
62. Cummins PM, von Offenberg SN, Killeen MT, Birney YA, Redmond EM, Cahill PA. Cyclic strain-mediated matrix metalloproteinase regulation within the vascular endothelium: a force to be reckoned with. Am J Physiol Heart Circ Physiol 2007; 292: H28-H42.
63. Kanse SM, Benzakour O, Kanthou C, Kost C, Lijnen HR, Preissner KT. Induction of vascular SMC proliferation by urokinase indicates a novel mechanism of action in vasoproliferative disorders. Arterioscler Thromb Vasc Biol 1997; 17: 2848-54.
64. Parfyonova Y, Plekhanova O, Solomatina M, et al. Contrasting effects of urokinase and tissue-type plasminogen activators on neointima formation and vessel remodelling after arterial injury. J Vasc Res 2004; 41: 268-76.
65. Sokabe T, Yamamoto K, Ohura N, et al. Differential regulation of urokinase-type plasminogen activator expression by fluid shear stress in human coronary artery endothelial cells. Am J Physiol Heart Circ Physiol 2004; 287: H2027-H2034.
66. Noris M, Morigi M, Donadelli R, et al. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res 1995; 76: 536-43.
67. Menshikov M, Plekhanova O, Cai H, et al. Urokinase plasminogen activator stimulates vascular smooth muscle cell proliferation via redox-dependent pathways. Arterioscler Thromb Vasc Biol 2006; 26: 801-7.
68. Brooks AR, Lelkes PI, Rubanyi GM. Gene expression profiling of human aortic endothelial cells exposed to disturbed flow and steady laminar flow. Physiol Genomics 2002; 9: 27-41.
69. Yoshizumi M, Abe J, Tsuchiya K, Berk BC, Tamaki T. Stress and vascular responses: atheroprotective effect of laminar fluid shear stress in endothelial cells: possible role of mitogen-activated protein kinases. J Pharmacol Sci 2003; 91: 172-6.
70. Liu SQ. Influence of tensile strain on smooth muscle cell orientation in rat blood vessels. J Biomech Eng 1998; 120: 313-20.
71. Nguyen KT, Frye SR, Eskin SG, Patterson C, Runge MS, McIntire LV. Cyclic strain increases protease-activated receptor-1 expression in vascular smooth muscle cells. Hypertension 2001; 38: 1038-43.
72. Frangos SG, Gahtan V, Sumpio B. Localization of atherosclerosis: role of hemodynamics. Arch Surg 1999; 134: 1142-9.
73. Jakkaraju S, Zhe X, Schuger L. Role of stretch in activation of smooth muscle cell lineage. Trends Cardiovasc Med 2003; 13: 330-5.
74. Lehoux S, Tedgui A. Cellular mechanics and gene expression in blood vessels. J Biomech 2003; 36: 631-43.
75. Schwartz SM, Campbell GR, Campbell JH. Replication of smooth muscle cells in vascular disease. Circ Res 1986; 58: 427-44.
76. Hedin U, Roy J, Tran PK. Control of smooth muscle cell proliferation in vascular disease. Curr Opin Lipidol 2004; 15: 559-65.
77. Stegemann JP, Nerem RM. Altered response of vascular smooth muscle cells to exogenous biochemical stimulation in two- and three-dimensional culture. Exp Cell Res 2003; 283: 146-55.
78. Song J, Worth NF, Rolfe BE, Campbell GR, Campbell JH. Heterogeneous distribution of isoactins in cultured vascular smooth muscle cells does not reflect segregation of contractile and cytoskeletal domains. J Histochem Cytochem 2000; 48: 1441-52.
79. Albinsson S, Nordstrom I, Hellstrand P. Stretch of the vascular wall induces smooth muscle differentiation by promoting actin polymerization. J Biol Chem 2004; 279: 34849-55.
80. Zeidan A, Sward K, Nordstrom I, et al. Ablation of SM22alpha decreases contractility and actin contents of mouse vascular smooth muscle. FEBS Lett 2004; 562: 141-6.
81. Berk BC. Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev 2001; 81: 999-1030.
82. Iwasaki H, Eguchi S, Ueno H, Marumo F, Hirata Y. Mechanical stretch stimulates growth of vascular smooth muscle cells via epidermal growth factor receptor. Am J Physiol Heart Circ Physiol 2000; 278: H521-H529.
83. Wilson E, Vives F, Collins T, Ives HE. Strain-responsive regions in the platelet-derived growth factor-A gene promoter. Hypertension 1998; 31: 170-5.
84. Mills I, Letsou G, Rabban J, Sumpio B, Gewirtz H. Mechanosensitive adenylate cyclase activity in coronary vascular smooth muscle cells. Biochem Biophys Res Commun 1990; 171: 143-7.
85. Kanda K, Matsuda T. Behavior of arterial wall cells cultured on periodically stretched substrates. Cell Transplant 1993; 2: 475-84.
86. Standley PR, Obards TJ, Martina CL. Cyclic stretch regulates autocrine IGF-I in vascular smooth muscle cells: implications in vascular hyperplasia. Am J Physiol 1999; 276: E697-E705.
87. Cheng W, Li B, Kajstura J, et al. Stretch-induced programmed myocyte cell death. J Clin Invest 1995; 96: 2247-59.
88. Fisslthaler B, Popp R, Michaelis UR, Kiss L, Fleming I, Busse R. Cyclic stretch enhances the expression and activity of coronary endothelium- derived hyperpolarizing factor synthase. Hypertension 2001; 38: 1427-32.
89. Hishikawa K, Luscher TF. Pulsatile stretch stimulates superoxide production in human aortic endothelial cells. Circulation 1997; 96: 3610-6.
90. Shyu KG. Cellular and molecular effects of mechanical stretch on vascular cells and cardiac myocytes. Clin Sci 2009; 116: 377-89.
91. Ueba H, Kawakami M, Yaginuma T. Shear stress as an inhibitor of vascular smooth muscle cell proliferation. Role of transforming growth factor-beta 1 and tissue-type plasminogen activator. Arterioscler Thromb Vasc Biol 1997; 17: 1512-6.
92. Chiu JJ, Chen LJ, Chang SF, et al. Shear stress inhibits smooth muscle cell-induced inflammatory gene expression in endothelial cells: role of NF-kappaB. Arterioscler Thromb Vasc Biol 2005; 25: 963-9.
93. Gambillara V, Montorzi G, Haziza-Pigeon C, Stergiopulos N, Silacci P. Arterial wall response to ex vivo exposure to oscillatory shear stress. J Vasc Res 2005; 42: 535-44.
94. Wang DM, Tarbell JM. Modeling interstitial flow in an artery wall allows estimation of wall shear stress on smooth muscle cells. J Biomech Eng 1995; 117: 358-63.
95. Wagner CT, Durante W, Christodoulides N, Hellums JD, Schafer AI. Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J Clin Invest 1997; 100: 589-96.
96. Papadaki M, Tilton RG, Eskin SG, McIntire LV. Nitric oxide production by cultured human aortic smooth muscle cells: stimulation by fluid flow. Am J Physiol 1998; 274: H616-H626.
97. Alshihabi SN, Chang YS, Frangos JA, Tarbell JM. Shear stressinduced release of PGE2 and PGI2 by vascular smooth muscle cells. Biochem Biophys Res Commun 1996; 224: 808-14.
98. Nishida M, Matsuno H, Kozawa O, et al. tPA, but not uPA, significantly affects antithrombotic therapy by a glycoprotein IIb/IIIa antagonist, but not by a factor Xa inhibitor. J Cardiovasc Pharmacol 2000; 36: 770-5.
99. Diamond SL, Eskin SG, McIntire LV. Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells. Science 1989; 243: 1483-5.
100. Diamond SL, Sharefkin JB, Dieffenbach C, Frasier-Scott K, McIntire LV, Eskin SG. Tissue plasminogen activator messenger RNA levels increase in cultured human endothelial cells exposed to laminar shear stress. J Cell Physiol 1990; 143: 364-71.
101. Ulfhammer E, Carlstrom M, Bergh N, Larsson P, Karlsson L, Jern S. Suppression of endothelial t-PA expression by prolonged high laminar shear stress. Biochem Biophys Res Commun 2009; 379: 532-6.
102. Clowes AW, Clowes MM, Au YP, Reidy MA, Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res 1990; 67: 61-7.
103. Grobmyer SR, Kuo A, Orishimo M, Okada SS, Cines DB, Barnathan ES. Determinants of binding and internalization of tissue-type plasminogen activator by human vascular smooth muscle and endothelial cells. J Biol Chem 1993; 268: 13291-300.
104. Papadaki M, Ruef J, Nguyen KT, et al. Differential regulation of protease activated receptor-1 and tissue plasminogen activator expression by shear stress in vascular smooth muscle cells. Circ Res 1998; 83: 1027-34.
105. Vernon SM, Campos MJ, Haystead T, Thompson MM, DiCorleto PE, Owens GK. Endothelial cell-conditioned medium downregulates smooth muscle contractile protein expression. Am J Physiol 1997; 272: C582-C591.
106. Vanhoutte PM. Endothelium and control of vascular function. State of the Art lecture. Hypertension 1989; 13: 658-67.
107. Heydarkhan-Hagvall S, Helenius G, Johansson BR, Li JY, Mattsson E, Risberg B. Co-culture of endothelial cells and smooth muscle cells affects gene expression of angiogenic factors. J Cell Biochem 2003; 89: 1250-9.
108. Hermida RC, Calvo C, Ayala DE, Fernandez JR, Ruilope LM, Lopez JE. Evaluation of the extent and duration of the "ABPM effect" in hypertensive patients. J Am Coll Cardiol 2002; 40: 710-7.
109. Fillinger MF, Sampson LN, Cronenwett JL, Powell RJ, Wagner RJ. Coculture of endothelial cells and smooth muscle cells in bilayer and conditioned media models. J Surg Res 1997; 67: 169-78.
110. Rose SL, Babensee JE. Complimentary endothelial cell/smooth muscle cell co-culture systems with alternate smooth muscle cell phenotypes. Ann Biomed Eng 2007; 35: 1382-90.
111. Vouyouka AG, Jiang Y, Basson MD. Pressure alters endothelial effects upon vascular smooth muscle cells by decreasing smooth muscle cell proliferation and increasing smooth muscle cell apoptosis. Surgery 2004; 136: 282-90.
112. Chiu JJ, Chen LJ, Chen CN, Lee PL, Lee CI. A model for studying the effect of shear stress on interactions between vascular endothelial cells and smooth muscle cells. J Biomech 2004; 37: 531-9.
113. Hsiai TK. Mechanosignal transduction coupling between endothelial and smooth muscle cells: role of hemodynamic forces. Am J Physiol Cell Physiol 2008; 294: C659-C661.
114. Lavender MD, Pang Z, Wallace CS, Niklason LE, Truskey GA. A system for the direct co-culture of endothelium on smooth muscle cells. Biomaterials 2005; 26: 4642-53.
115. Hirschi KK, Rohovsky SA, D'Amore PA. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 1998; 141: 805-14.
116. Feng J, Chan-Park MB, Shen J, Chan V. Quick layer-by-layer assembly of aligned multilayers of vascular smooth muscle cells in deep microchannels. Tissue Eng 2007; 13: 1003-12.
117. VanBavel E. Effects of shear stress on endothelial cells: possible relevance for ultrasound applications. Prog Biophys Mol Biol 2007; 93: 374-83.
118. Zeng Y, Qiao Y, Zhang Y, Liu X, Wang Y, Hu J. Effects of fluid shear stress on apoptosis of cultured human umbilical vein endothelial cells induced by LPS. Cell Biol Int 2005; 29: 932-5.
119. Sucosky P, Balachandran K, Elhammali A, Jo H, Yoganathan AP. Altered shear stress stimulates upregulation of endothelial VCAM-1 and ICAM-1 in a BMP-4- and TGF-beta1-dependent pathway. Arterioscler Thromb Vasc Biol 2009; 29: 254-60.
120. Ziegler T, Alexander RW, Nerem RM. An endothelial cell-smooth muscle cell co-culture model for use in the investigation of flow effects on vascular biology. Ann Biomed Eng 1995; 23: 216-25.
121. Redmond EM, Cahill PA, Sitzmann JV. Perfused transcapillary smooth muscle and endothelial cell co-culture--a novel in vitro model. In Vitro Cell Dev Biol Anim 1995; 31: 601-9.
122. Nackman GB, Fillinger MF, Shafritz R, Wei T, Graham AM. Flow modulates endothelial regulation of smooth muscle cell proliferation: a new model. Surgery 1998; 124: 353-60.
123. Rainger GE, Stone P, Morland CM, Nash GB. A novel system for investigating the ability of smooth muscle cells and fibroblasts to regulate adhesion of flowing leukocytes to endothelial cells. J Immunol Methods 2001; 255: 73-82.
124. Chiu JJ, Chen LJ, Lee PL, et al. Shear stress inhibits adhesion molecule expression in vascular endothelial cells induced by coculture with smooth muscle cells. Blood 2003; 101: 2667-74.
125. Nagel T, Resnick N, Atkinson WJ, Dewey CF, Jr., Gimbrone MA, Jr. Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J Clin Invest 1994; 94: 885-91.
126. Tsuboi H, Ando J, Korenaga R, Takada Y, Kamiya A. Flow stimulates ICAM-1 expression time and shear stress dependently in cultured human endothelial cells. Biochem Biophys Res Commun 1995; 206: 988-96.
127. Ohtsuka A, Ando J, Korenaga R, Kamiya A, Toyama-Sorimachi N, Miyasaka M. The effect of flow on the expression of vascular adhesion molecule-1 by cultured mouse endothelial cells. Biochem Biophys Res Commun 1993; 193: 303-10.
128. Korenaga R, Ando J, Kosaki K, Isshiki M, Takada Y, Kamiya A. Negative transcriptional regulation of the VCAM-1 gene by fluid shear stress in murine endothelial cells. Am J Physiol 1997; 273: C1506-C1515.
129. Chiu JJ, Wung BS, Shyy JY, Hsieh HJ, Wang DL. Reactive oxygen species are involved in shear stress-induced intercellular adhesion molecule-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol 1997; 17: 3570-7.
130. Subbotin VM. Analysis of arterial intimal hyperplasia: review and hypothesis. Theor Biol Med Model 2007; 4: 41.
131. Newby AC, Zaltsman AB. Molecular mechanisms in intimal hyperplasia. J Pathol 2000; 190: 300-9.
132. John LC. Biomechanics of coronary artery and bypass graft disease: potential new approaches. Ann Thorac Surg 2009; 87: 331-8.
133. Kohler TR, Kirkman TR, Kraiss LW, Zierler BK, Clowes AW. Increased blood flow inhibits neointimal hyperplasia in endothelialized vascular grafts. Circ Res 1991; 69: 1557-65.
134. Geary RL, Kohler TR, Vergel S, Kirkman TR, Clowes AW. Time course of flow-induced smooth muscle cell proliferation and intimal thickening in endothelialized baboon vascular grafts. Circ Res 1994; 74: 14-23.
135. Swift MR, Weinstein BM. Arterial-venous specification during development. Circ Res 2009; 104: 576-88.
136. Fisher SA, Langille BL, Srivastava D. Apoptosis during cardiovascular development. Circ Res 2000; 87: 856-64.
137. Berceli SA, Davies MG, Kenagy RD, Clowes AW. Flow-induced neointimal regression in baboon polytetrafluoroethylene grafts is associated with decreased cell proliferation and increased apoptosis. J Vasc Surg 2002; 36: 1248-55.
138. Kenagy RD, Fischer JW, Davies MG, et al. Increased plasmin and serine proteinase activity during flow-induced intimal atrophy in baboon PTFE grafts. Arterioscler Thromb Vasc Biol 2002; 22: 400-4.
139. Cho A, Mitchell L, Koopmans D, Langille BL. Effects of changes in blood flow rate on cell death and cell proliferation in carotid arteries of immature rabbits. Circ Res 1997; 81: 328-37.
140. Kenagy RD, Fischer JW, Lara S, Sandy JD, Clowes AW, Wight TN. Accumulation and loss of extracellular matrix during shear stress-mediated intimal growth and regression in baboon vascular grafts. J Histochem Cytochem 2005; 53: 131-40.
141. Schmedlen RH, Elbjeirami WM, Gobin AS, West JL. Tissue engineered small-diameter vascular grafts. Clin Plast Surg 2003; 30: 507-17.
142. Dridi SM, Foucault BA, Igondjo TS, et al. Vascular wall remodeling in patients with supravalvular aortic stenosis and Williams Beuren syndrome. J Vasc Res 2005; 42: 190-201.
143. Mitra AK, Gangahar DM, Agrawal DK. Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia. Immunol Cell Biol 2006; 84: 115-24.
144. Flanagan TC, Tschoeke B, Diamantouros S, Schmitz-Rode T, Jockenhoevel S. Mechanical properties of tissue-engineered vascular grafts: response to letter to the editor. Artif Organs 2009; 33: 194-6.
145. Kerdjoudj H, Berthelemy N, Rinckenbach S, et al. Small vessel replacement by human umbilical arteries with polyelectrolyte filmtreated arteries: in vivo behavior. J Am Coll Cardiol 2008; 52: 1589-97.
146. Loth F, Fischer PF, Bassiouny HS. Blood flow in end-to-side anastomoses*. Ann Rev Fluid Mech 2008; 40: 367-93.
147. Seifalian AM, Filippatos TD, Joshi J, Mikhailidis DP. Obesity and Arterial Compliance Alterations. Curr Vasc Pharmacol 2010; 8(2): 155-68.
148. Willis DJ, Kalish JA, Li C, et al. Temporal gene expression following prosthetic arterial grafting. J Surg Res 2004; 120: 27-36.
149. Tuomisto TT, Yla-Herttuala S. What have we learnt about microarray analyses of atherogenesis? Curr Opin Lipidol 2005; 16: 201-5.
150. Stone DH, Sivamurthy N, Contreras MA, Fitzgerald L, LoGerfo FW, Quist WC. Altered ubiquitin/proteasome expression in anastomotic intimal hyperplasia. J Vasc Surg 2001; 34: 1016-22.
151. Geary RL, Wong JM, Rossini A, Schwartz SM, Adams LD. Expression profiling identifies 147 genes contributing to a unique primate neointimal smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 2002; 22: 2010-6.
152. Kalish JA, Willis DJ, Li C, et al. Temporal genomics of vein bypass grafting through oligonucleotide microarray analysis. J Vasc Surg 2004; 39: 645-54.
153. Sarjeant JM, Rabinovitch M. Understanding and treating vein graft atherosclerosis. Cardiovasc Pathol 2002; 11: 263-71.
154. Isoda K, Nishikawa K, Kamezawa Y, et al. Osteopontin plays an important role in the development of medial thickening and neointimal formation. Circ Res 2002; 91: 77-82.
155. van der Loop FT, Gabbiani G, Kohnen G, Ramaekers FC, van Eys GJ. Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. Arterioscler Thromb Vasc Biol 1997; 17: 665-71.
156. Cao R, Brakenhielm E, Pawliuk R, et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 2003; 9: 604-13.
157. Roy-Chaudhury P, Kelly BS, Miller MA, et al. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int 2001; 59: 2325-34.
158. Sapienza P, di Marzo L, Cucina A, et al. Release of PDGF-BB and bFGF by human endothelial cells seeded on expanded polytetrafluoroethylene vascular grafts. J Surg Res 1998; 75: 24-9.
159. Chan-Park MB, Shen JY, Cao Y, et al. Biomimetic control of vascular smooth muscle cell morphology and phenotype for functional tissue-engineered small-diameter blood vessels. J Biomed Mater Res A 2009; 88: 1104-21.
160. Pitsch RJ, Minion DJ, Goman ML, van Aalst JA, Fox PL, Graham LM. Platelet-derived growth factor production by cells from Dacron grafts implanted in a canine model. J Vasc Surg 1997; 26: 70-8.
161. Parang P, Arora R. Coronary vein graft disease: pathogenesis and prevention. Can J Cardiol 2009; 25: e57-e62.
162. Jeon BH, Chang SJ, Kim JW, Hong YM, Yoon SY, Choe IS. Effect of high blood flow on the expression of endothelial constitutive nitric oxide synthase in rats with femoral arteriovenous shunts. Endothelium 2000; 7: 243-52.
163. Vara DS, Punshon G, Sales KM, Hamilton G, Seifalian AM. The effect of shear stress on human endothelial cells seeded on cylindrical viscoelastic conduits: an investigation of gene expression. Biotechnol Appl Biochem 2006; 45: 119-30.
164. Zhang JY, Beckman EJ, Piesco NP, Agarwal S. A new peptidebased urethane polymer: synthesis, biodegradation, and potential to support cell growth in vitro. Biomaterials 2000; 21: 1247-58.
165. Menconi MJ, Owen T, Dasse KA, Stein G, Lian JB. Molecular approaches to the characterization of cell and blood/biomaterial interactions. J Card Surg 1992; 7: 177-87.
166. Vara DS, Punshon G, Sales KM, et al. Development of an RNA isolation procedure for the characterisation of human endothelial cell interactions with polyurethane cardiovascular bypass grafts. Biomaterials 2005; 26: 3987-93.
167. John LCH. Biomechanics of coronary artery and bypass graft disease: potential new approaches. Ann Thorac Surg 2009; 87: 331-8.
168. Li S, Lao J, Chen BP, et al. Genomic analysis of smooth muscle cells in 3-dimensional collagen matrix. FASEB J 2003; 17: 97-9.
169. Vailhe B, Vittet D, Feige JJ. In vitro models of vasculogenesis and angiogenesis. Lab Invest 2001; 81: 439-52.
170. Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci U S A 1986; 83: 7297-301.
171. Milkiewicz M, Brown MD, Egginton S, Hudlicka O. Association between shear stress, angiogenesis, and VEGF in skeletal muscles in vivo. Microcirculation 2001; 8: 229-41.
172. Gloe T, Sohn HY, Meininger GA, Pohl U. Shear stress-induced release of basic fibroblast growth factor from endothelial cells is mediated by matrix interaction via integrin alpha(v)beta3. J Biol Chem 2002; 277: 23453-8.
173. Nolan K, Millet Y, Ricordi C, Stabler CL. Tissue engineering and biomaterials in regenerative medicine. Cell Transplant 2008; 17: 241-3.
174. de Mel A, Bolvin C, Edirisinghe M, Hamilton G, Seifalian AM. Development of cardiovascular bypass grafts: endothelialization and applications of nanotechnology. Expert Rev Cardiovasc Ther 2008; 6: 1259-77.
175. Lu X, Wang R. [Culture and identify the endothelial cells of human umbilical vein]. Wei Sheng Yan Jiu 2001; 30: 188-9.
176. Xiao L and Shi D. Role of precoating in artificial vessel endothelialization. Chin J Traumatol 2004; 7: 312-6.
177. Yazdani SK, Watts B, Machingal M, Jarajapu YP, Van Dyke ME, Christ GJ. Smooth muscle cell seeding of decellularized scaffolds: the importance of bioreactor preconditioning to development of a more native architecture for tissue-engineered blood vessels. Tissue Eng Part A 2009; 15: 827-40.
178. Schnittler HJ, Franke RP, Fuhrmann R, et al. Influence of various substrates on the actin filament system of cultured human vascular endothelial cells exposed to fluid shear stress. In: Zilla P, Fasol R, Deutsch M, Eds. Endothelialization of Vascular Grafts, S Karger AG: Basel 1987; pp. 183-8.
179. Kaehler J, Zilla P, Fasol R, Deutsch M, Kadletz M. Precoating substrate and surface configuration determine adherence and spreading of seeded endothelial cells on polytetrafluoroethylene grafts. J Vasc Surg 1989; 9: 535-41.
180. Baguneid M, Murray D, Salacinski HJ, et al. Shear-stress preconditioning and tissue-engineering-based paradigms for generating arterial substitutes. Biotechnol Appl Biochem 2004; 39: 151-7.
181. Cardinal KO, Bonnema GT, Hofer H, Barton JK, Williams SK. Tissue-engineered vascular grafts as in vitro blood vessel mimics for the evaluation of endothelialization of intravascular devices. Tissue Eng 2006; 12: 3431-8.
182. Fernandez P, Deguette A, Pothuaud L, Belleannee G, Coste P, Bordenave L. Quality control assessment of ePTFE precoating procedure for in vitro endothelial cell seeding. Biomaterials 2005; 26: 5042-7.
183. Meinhart JG, Deutsch M, Fischlein T, Howanietz N, Froschl A, Zilla P. Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann Thorac Surg 2001; 71: S327-S331.
184. Lamm P, Juchem G, Milz S, Schuffenhauer M, Reichart B. Autologous endothelialized vein allograft: a solution in the search for small-caliber grafts in coronary artery bypass graft operations. Circulation 2001; 104: I108-14.
185. Kumar TR, Krishnan LK. Fibrin-mediated endothelial cell adhesion to vascular biomaterials resists shear stress due to flow. J Mater Sci Mater Med 2002; 13: 751-5.
186. Yu H, Wang Y, Eton D, et al. Dual cell seeding and the use of zymogen tissue plasminogen activator to improve cell retention on polytetrafluoroethylene grafts. J Vasc Surg 2001; 34: 337-43.
187. Yu H, Dai W, Yang Z, et al. Smooth muscle cells improve endothelial cell retention on polytetrafluoroethylene grafts in vivo. J Vasc Surg 2003; 38: 557-63.
188. Tschoeke B, Flanagan TC, Koch S, et al. Tissue engineered smallcaliber vascular graft based on novel biodegradable composite fibrin- polylactide scaffold. Tissue Eng Part A 2009; 15: 1909-18.
189. Nerem RM, Seliktar D. Vascular tissue engineering. Ann Rev Biomedic Eng 2001; 3: 225-43.
190. Stitzel JD, Pawlowski KJ, Wnek GE, Simpson DG, Bowlin GL. Arterial smooth muscle cell proliferation on a novel biomimicking, biodegradable vascular graft scaffold. J Biomater Appl 2001; 16: 22-33.
191. Clowes MM, Lynch CM, Miller AD, Miller DG, Osborne WR, Clowes AW. Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes. J Clin Invest 1994; 93: 644-51.
192. Geary RL, Clowes AW, Lau S, Vergel S, Dale DC, Osborne WR. Gene transfer in baboons using prosthetic vascular grafts seeded with retrovirally transduced smooth muscle cells: a model for local and systemic gene therapy. Hum Gene Ther 1994; 5: 1211-6.
193. Huber TS, Welling TH, Sarkar R, Messina LM, Stanley JC. Effects of retroviral-mediated tissue plasminogen activator gene transfer and expression on adherence and proliferation of canine endothelial cells seeded onto expanded polytetrafluoroethylene. J Vasc Surg 1995; 22: 795-803.
194. Dunn PF, Newman KD, Jones M, et al. Seeding of vascular grafts with genetically modified endothelial cells. Secretion of recombinant TPA results in decreased seeded cell retention in vitro and in vivo. Circulation 1996; 93: 1439-46.
195. Hsu SH, Sun SH, Chen DC. Improved retention of endothelial cells seeded on polyurethane small-diameter vascular grafts modified by a recombinant RGD-containing protein. Artif Organs 2003; 27: 1068-78.
196. Sentissi JM, Ramberg K, O'Donnell TF, Jr., Connolly RJ, Callow AD. The effect of flow on vascular endothelial cells grown in tissue culture on polytetrafluoroethylene grafts. Surgery 1986; 99: 337-43.
197. Hsu SH, Tsai IJ, Lin DJ, Chen DC. The effect of dynamic culture conditions on endothelial cell seeding and retention on small diameter polyurethane vascular grafts. Med Eng Phys 2005; 27: 267-72.
198. Greisler HP, Johnson S, Joyce K, et al. The effects of shear stress on endothelial cell retention and function on expanded polytetrafluoroethylene. Arch Surg 1990; 125: 1622-5.
199. Brakemeier S, Eichler I, Hopp H, Kohler R, Hoyer J. Up-regulation of endothelial stretch-activated cation channels by fluid shear stress. Cardiovasc Res 2002; 53: 209-18.
200. Marcet-Palacios M, Graham K, Cass C, Befus AD, Mayers I, Radomski MW. Nitric oxide and cyclic GMP increase the expression of matrix metalloproteinase-9 in vascular smooth muscle. J Pharmacol Exp Ther 2003; 307: 429-36.
201. Ott MJ, Ballermann BJ. Shear stress-conditioned, endothelial cellseeded vascular grafts: improved cell adherence in response to in vitro shear stress. Surgery 1995; 117: 334-9.
202. Ballermann BJ, Ott MJ. Adhesion and differentiation of endothelial cells by exposure to chronic shear stress: a vascular graft model. Blood Purif 1995; 13: 125-34.
203. Gulbins H, Pritisanac A, Petzold R, et al. A low-flow adaptation phase improves shear-stress resistance of artificially seeded endothelial cells. Thorac Cardiovasc Surg 2005; 53: 96-102.
204. Lee YS, Park DK, Kim YB, Seo JW, Lee KB, Min BG. Endothelial cell seeding onto the extracellular matrix of fibroblasts for the development of a small diameter polyurethane vessel. ASAIO J 1993; 39: M740-M745.
205. Fridman R, Alon Y, Doljanski F, Fuks Z, Vlodavsky I. Cell interaction with the extracellular matrices produced by endothelial cells and fibroblasts. Exp Cell Res 1985; 158: 461-76.
206. Miyata T, Conte MS, Trudell LA, Mason D, Whittemore AD, Birinyi LK. Delayed exposure to pulsatile shear stress improves retention of human saphenous vein endothelial cells on seeded ePTFE grafts. J Surg Res 1991; 50: 485-93.
207. Giudiceandrea A, Seifalian AM, Krijgsman B, Hamilton G. Effect of prolonged pulsatile shear stress in vitro on endothelial cell seeded PTFE and compliant polyurethane vascular grafts. Eur J Vasc Endovasc Surg 1998; 15: 147-54.
208. Gulbins H, Dauner M, Petzold R, et al. Development of an artificial vessel lined with human vascular cells. J Thorac Cardiovasc Surg 2004; 128: 372-7.
209. Seliktar D, Nerem RM, Galis ZS. The role of matrix metalloproteinase-2 in the remodeling of cell-seeded vascular constructs subjected to cyclic strain. Ann Biomed Eng 2001; 29: 923-34.
210. Stegemann JP, Nerem RM. Phenotype modulation in vascular tissue engineering using biochemical and mechanical stimulation. Ann Biomed Eng 2003; 31: 391-402.
211. Feugier P, Black RA, Hunt JA, How TV. Attachment, morphology and adherence of human endothelial cells to vascular prosthesis materials under the action of shear stress. Biomaterials 2005; 26: 1457-66.
212. Wolf S, Werthessen NT. Dynamics of arterial flow. Adv Exp Med Biol 1979; 115: 1-472.
213. Dewey CF, Jr., Bussolari SR, Gimbrone MA, Jr., Davies PF. The dynamic response of vascular endothelial cells to fluid shear stress. J Biomech Eng 1981; 103: 177-85.
214. Langille LB. Integrity of arterial endothelium following acute exposure to high shear stress. Biorheology 1984; 21: 333-46.
215. Pratt KJ, Williams SK, Jarrell BE. Enhanced adherence of human adult endothelial cells to plasma discharge modified polyethylene terephthalate. J Biomed Mater Res 1989; 23: 1131-47.
216. Reutelingsperger C, Van Goll R, Heijnen V, Frederik P, Lindhout T. The rotating disc as a device to study the adhesive properties of endothelial cells under differential shear stresses. J Mater: Sci Mater Med 2005; 5: 361-7.
217. Dunkern TR, Paulitschke M, Meyer R, et al. A novel perfusion system for the endothelialisation of PTFE grafts under defined flow. Eur J Vasc Endovasc Surg 1999; 18: 105-10.
218. Pratt KJ, Jarrell BE, Williams SK, Carabasi RA, Rupnick MA, Hubbard FA. Kinetics of endothelial cell-surface attachment forces. J Vasc Surg 1988; 7: 591-9.
219. Walluscheck KP, Steinhoff G, Kelm S, Haverich A. Improved endothelial cell attachment on ePTFE vascular grafts pretreated with synthetic RGD-containing peptides. Eur J Vasc Endovasc Surg 1996; 12: 321-30.
220. Schneider A, Chandra M, Lazarovici G, et al. Naturally produced extracellular matrix is an excellent substrate for canine endothelial cell proliferation and resistance to shear stress on PTFE vascular grafts. Thromb Haemost 1997; 78: 1392-8.
221. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998; 97: 916-31.
222. Fatourou EM, Paraskevas KI, Seifalian AM, Hamilton G, Mikhailidis DP. The role of established and emerging risk factors in peripheral vascular graft occlusion. Expert Opin Pharmacother 2007; 8: 901-11.
223. Kulik A, Chan V, Ruel M. Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy. Expert Opin Drug Saf 2009; 8: 169-82.
224. Gavaghan TP, Gebski V, Baron DW. Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study. Circulation 1991; 83: 1526-33.
225. Brumberg RS, Back MR, Armstrong PA, et al. The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure. J Vasc Surg 2007; 46: 1160-6.
226. LeCroy CJ, Patterson MA, Taylor SM, Westfall AO, Jordan WD, Jr. Effect of warfarin anticoagulation on below-knee polytetrafluoroethylene graft patency. Ann Vasc Surg 2005; 19: 192-8.
227. Kulik A, Le MM, Wells GA, Mesana TG, Ruel M. The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin vs. aspirin alone after coronary bypass surgery [NCT00228423]. Curr Control Trials Cardiovasc Med 2005; 6: 15.
228. Gao C, Ren C, Li D, Li L. Clopidogrel and aspirin vs. clopidogrel alone on graft patency after coronary artery bypass grafting. Ann Thorac Surg 2009; 88: 59-62.
229. Ibrahim K, Tjomsland O, Halvorsen D, et al. Effect of clopidogrel on midterm graft patency following off-pump coronary revascularization surgery. Heart Surg Forum 2006; 9: E581-E856.
230. Lu JM, Wang X, Marin-Muller C, et al. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn 2009; 9: 325-41.
231. Sollott SJ, Cheng L, Pauly RR, et al. Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J Clin Invest 1995; 95: 1869-76.
232. Voisard R, Seitzer U, Baur R, et al. A prescreening system for potential antiproliferative agents: implications for local treatment strategies of postangioplasty restenosis. Int J Cardiol 1995; 51: 15-28.
233. Fischer JW. Dexamethasone: effects on neointimal hyperplasia and vessel integrity. Cardiovasc Res 2005; 68: 350-352.
234. Huang Y, Wang L, Verweire I, et al. Optimization of local methylprednisolone delivery to inhibit inflammatory reaction and neointimal hyperplasia of coated coronary stents. J Invasive Cardiol 2002; 14: 505-513.
235. Karakayali F, Haberal N, Tufan H, et al. Evaluation of neointimal hyperplasia on tranilast-coated synthetic vascular grafts: an experimental study. J Invest Surg 2007; 20: 167-73.
236. Ansel GM, Lumsden AB. Evolving modalities for femoropopliteal interventions. J Endovasc Ther 2009; 16: II82-II97.
237. Jorgensen CS, Paaske WP. Physical and mechanical properties of ePTFE stretch vascular grafts determined by time-resolved scanning acoustic microscopy. Eur J Vasc Endovasc Surg 1998; 15: 416-22.
238. Oltrona L, Eisenberg PR, Abendschein DR, Rubin BG. Efficacy of local inhibition of procoagulant activity associated with smalldiameter prosthetic vascular grafts. J Vasc Surg 1996; 24: 624-31.
239. Giardino EC, Haertlein BJ, de GL, et al. Cooperative antithrombotic effect from the simultaneous inhibition of thrombin and factor Xa. Blood Coagul Fibrinolysis 2010; 21: 128-34.
240. Meijers JC, Tekelenburg WL, Bouma BN, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 2000; 342: 696-701.
241. Gross PL, Weitz JI. New antithrombotic drugs. Clin Pharmacol Ther 2009; 86: 139-46.
242. Rothman MT. Drug insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options. Nat Clin Pract Cardiovasc Med 2005; 2: 465-74.
243. Beguin S, Lindhout T, Hemker HC. The mode of action of heparin in plasma. Thromb Haemost 1988; 60: 457-62.
244. Huntington JA, Gettins PG. Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin. Biochemistry 1998; 37: 3272-7.
245. Parolari A, Guarnieri D, Alamanni F, et al. Platelet function and anesthetics in cardiac surgery: an in vitro and ex vivo study. Anesth Analg 1999; 89: 26-31.
246. Walluscheck KP, Bierkandt S, Brandt M, Cremer J. Infrainguinal ePTFE vascular graft with bioactive surface heparin bonding. First clinical results. J Cardiovasc Surg (Torino) 2005; 46: 425-30.
247. Istvan ES, Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science 2001; 292: 1160-4.
248. Lima JA, Desai MY, Steen H, Warren WP, Gautam S, Lai S. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. Circulation 2004; 110: 2336-41.
249. Alnaeb ME, Alobaid N, Seifalian AM, Mikhailidis DP, Hamilton G. Statins and peripheral arterial disease: potential mechanisms and clinical benefits. Ann Vasc Surg 2006; 20: 696-705.
250. Heat Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
251. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-78.
252. Davis M, Atwal AS, Nair DR, et al. The effect of short-term lipid lowering with atorvastatin on carotid artery intima media thickness in patients with peripheral vascular disease: a pilot study. Curr Med Res Opin 2000; 16: 198-204.
253. Kulik A, Levin R, Ruel M, Mesana TG, Solomon DH, Choudhry NK. Patterns and predictors of statin use after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2007; 134: 932-8.
254. Youssef F, Seifalian AM, Jagroop IA, et al. The early effect of lipid-lowering treatment on carotid and femoral intima media thickness (IMT). Eur J Vasc Endovasc Surg 2002; 23: 358-64.
255. Abbruzzese TA, Havens J, Belkin M, et al. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg 2004; 39: 1178-85.
256. Hong MK, Mintz GS, Hong MK, et al. Intravascular ultrasound assessment of the presence of vascular remodeling in diseased human saphenous vein bypass grafts. Am J Cardiol 1999; 84: 992-8.
257. Campeau L, Hunninghake DB, Knatterud GL, et al. Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators. Circulation 1999; 99: 3241-7.
258. Sainani GS, Maru VG, Mehra AP. Role of endothelin-1 in genesis of coronary artery disease. Indian Heart J 2005; 57: 121-7.
259. Kleinz MJ, Davenport AP. Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regul Pept 2004; 118: 119-25.
260. Maguire JJ, Davenport AP. ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro. Br J Pharmacol 1995; 115: 191-7.
261. Masood I, Porter KE, London NJ, Pringle JH. Endothelin-1 expression in vein graft stenosis. J Vasc Surg 1996; 24: 901-2.
262. Bohm F, Johansson BL, Hedin U, Alving K, Pernow J. Enhanced vasoconstrictor effect of big endothelin-1 in patients with atherosclerosis: relation to conversion to endothelin-1. Atherosclerosis 2002; 160: 215-22.
263. Bond BR, Dorman BH, Clair MJ, et al. Endothelin-1 during and after cardiopulmonary bypass: association to graft sensitivity and postoperative recovery. J Thorac Cardiovasc Surg 2001; 122: 358-64.
264. Dashwood MR. Endothelin-1 and vein graft occlusion in patients undergoing bypass surgery. Eur J Clin Invest 2009; 39 (Suppl 2): 78-87.
265. Sampath R, Kukielka GL, Smith CW, Eskin SG, McIntire LV. Shear stress-mediated changes in the expression of leukocyte adhesion receptors on human umbilical vein endothelial cells in vitro. Ann Biomed Eng 1995; 23: 247-56.
266. Walpola PL, Gotlieb AI, Cybulsky MI, Langille BL. Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress. Arterioscler Thromb Vasc Biol 1995; 15: 2-10.
267. Frangos JA, Eskin SG, McIntire LV, Ives CL. Flow effects on prostacyclin production by cultured human endothelial cells. Science 1985; 227: 1477-9.
268. von Offenberg SN, Cummins PM, Birney YA, Cullen JP, Redmond EM, Cahill PA. Cyclic strain-mediated regulation of endothelial matrix metalloproteinase-2 expression and activity. Cardiovasc Res 2004; 63: 625-34.
269. Negishi M, Lu D, Zhang YQ, et al. Upregulatory expression of furin and transforming growth factor-beta by fluid shear stress in vascular endothelial cells. Arterioscler Thromb Vasc Biol 2001; 21: 785-90.
270. Hsieh HJ, Li NQ, Frangos JA. Shear stress increases endothelial platelet-derived growth factor mRNA levels. Am J Physiol 1991; 260: H642-H646.
271. Eng E, Ballermann BJ. Diminished NF-kappaB activation and PDGF-B expression in glomerular endothelial cells subjected to chronic shear stress. Microvasc Res 2003; 65: 137-44.
272. Sumpio BE, Du W, Galagher G, et al. Regulation of PDGF-B in endothelial cells exposed to cyclic strain. Arterioscler Thromb Vasc Biol 1998; 18: 349-55.
273. Passerini AG, Milsted A, Rittgers SE. Shear stress magnitude and directionality modulate growth factor gene expression in preconditioned vascular endothelial cells. J Vasc Surg 2003; 37: 182-90.
274. Malek AM, Gibbons GH, Dzau VJ, Izumo S. Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium. J Clin Invest 1993; 92: 2013-21.
275. Ohura N, Yamamoto K, Ichioka S, et al. Global analysis of shear stress-responsive genes in vascular endothelial cells. J Atheroscler Thromb 2003; 10: 304-13.
276. Li M, Scott D, Shandas R, Stenmark K, Tan W. High pulsatility flow induces adhesion molecule and cytokine mRNA expression in distal pulmonary artery endothelial cells. Ann Biomed Eng. 2009; 37: 1082-92.
277. Lawson C, Wolf S. ICAM-1 signaling in endothelial cells. Pharmacol Rep 2009; 61: 22-32.
278. Zakkar M, Chaudhury H, Sandvik G, et al. Increased endothelial mitogen-activated protein kinase phosphatase-1 expression suppresses proinflammatory activation at sites that are resistant to atherosclerosis. Circ Res 2008; 103: 726-32.
279. Partridge J, Carlsen H, Enesa K, et al. Laminar shear stress acts as a switch to regulate divergent functions of NF-{kappa}B in endothelial cells. FASEB J 2007; 21: 3553-61.
280. Rizzo V, Morton C, DePaola N, Schnitzer JE, Davies PF. Recruitment of endothelial caveolae into mechanotransduction pathways by flow conditioning in vitro. Am J Physiol Heart Circ Physiol 2003; 285: H1720-H1729.
281. Shyy YJ, Hsieh HJ, Usami S, Chien S. Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium. Proc Natl Acad Sci USA 1994; 91: 4678-82.
282. Iba T, Sumpio BE. Tissue plasminogen activator expression in endothelial cells exposed to cyclic strain in vitro. Cell Transplant 1992; 1: 43-50.
283. Sjogren LS, Doroudi R, Gan L, Jungersten L, Hrafnkelsdottir T, Jern S. Elevated intraluminal pressure inhibits vascular tissue plasminogen activator secretion and downregulates its gene expression. Hypertension 2000; 35: 1002-8.
284. Schneider PA, Hanson SR, Price TM, Harker LA. Durability of confluent endothelial cell monolayers on small-caliber vascular prostheses in vitro. Surgery 1988; 103: 456-62.
285. Kraiss LW, Kirkman TR, Kohler TR, Zierler B, Clowes AW. Shear stress regulates smooth muscle proliferation and neointimal thickening in porous polytetrafluoroethylene grafts. Arterioscler Thromb 1991; 11: 1844-52.
286. Stachelek SJ, Alferiev I, Choi H, et al. Cholesterol-derivatized polyurethane: characterization and endothelial cell adhesion. J Biomed Mater Res A 2005; 72: 200-12.
287. Williamson MR, Black R, Kielty C. PCL-PU composite vascular scaffold production for vascular tissue engineering: attachment, proliferation and bioactivity of human vascular endothelial cells. Biomaterials 2006; 27: 3608-16.
288. Nieponice A, Soletti L, Guan J, et al. Development of a tissueengineered vascular graft combining a biodegradable scaffold, muscle-derived stem cells and a rotational vacuum seeding technique. Biomaterials 2008; 29: 825-33.
289. Vara DS, Punshon G, Sales KM, Sarkar S, Hamilton G, Seifalian AM. Endothelial cell retention on a viscoelastic nanocomposite vascular conduit is improved by exposure to shear stress preconditioning prior to physiological flow. Artif Organs 2008; 32: 977-81.